Novel Coronavirus (SARS-CoV-2/COVID-19)
The Cybersecurity and Infrastructure Security Agency is tracking an unknown malicious cyber actor who is spoofing the Small Business Administration COVID-19 loan relief webpage via phishing emails, the agency announced.
The Department of Health and Human Services today said it will invest $6.5 million in two laboratories, Aegis Sciences Corporation and Sonic Healthcare USA, to add capacity for up to 4 million additional SARS-CoV-2 tests each month.
AHA, along with the American College of Surgeons, American Society of Anesthesiologists and Association of periOperative Registered Nurses, released Joint Statement: Roadmap for Maintaining Essential Surgery During COVID-19 Pandemic, an update to a previous joint statement released in April.
The recent surge of COVID-19 cases in Central Florida affects the residents in seven Florida counties: Orange, Seminole, Osceola, Polk, Volusia, Flagler and Lake. The counties are central to AdventHealth’s Central Florida Division, which includes 21 hospitals and more than 30 urgent care centers,…
The FBI’s Baltimore Field Office, in coordination with Office of Private Sector (OPS), prepared this LIR to inform private sector partners about recent Personal Protective Equipment (PPE) fraud schemes targeting the Healthcare Sector.
This AHA Special Bulletin provides a list of principles and considerations to guide physicians, nurses, and hospitals and health systems for providing essential care during the ongoing public health emergency.
ACS, AHA, ASA, and AORN develop roadmap for safely managing surgical patients during a time of resurgence
The following is a list of principles and considerations to guide physicians, nurses and local facilities in their care in operating rooms and all procedural areas during the ongoing pandemic.
The Food and Drug Administration released FAQs describing the procedures for importing respirators, face masks, and other personal protective equipment or medical devices for which the agency has issued an emergency use authorization or enforcement discretion policy during the COVID-19 pandemic.
The departments of Health and Human Services and Defense will pay Moderna Inc. about $1.5 billion to produce and deliver 100 million doses of its COVID-19 vaccine candidate to vaccinate Americans if authorized by the Food and Drug Administration, the agencies announced.